Drug recall D-0457-2021
Product
Jentadueto XR (linagliptin and metformin hydrochloride extended-release) Tablets 5 mg/1000 mg 30 tablets Rx only NDC 0597-0275-33 Dist. by: Boehringer Ingleheim (BI) Pharmaceuticals, Inc. Ridgefield, CT 06877 USA
Reason for recall
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Lots and codes
3189866
Recall details
- Recalling firm
- Cardinal Health Inc., Dublin, OH
- Quantity
- 52 bottles
- Distribution
- FL, GA, SC
- Type
- Voluntary: Firm initiated
- Recall initiated
- March 15, 2021
- Terminated
- June 17, 2024
Related products
- Jentadueto XR – drug information
- NDC 0597-0275 Jentadueto XR · Linagliptin 5 mg/1; Metformin Hydrochloride 1000 mg/1 · Boehringer Ingelheim Pharmaceuticals, Inc.
- NDC 0597-0270 Jentadueto XR · Linagliptin 2.5 mg/1; Metformin Hydrochloride 1000 mg/1 · Boehringer Ingelheim Pharmaceuticals, Inc.